User: esg Topic: Health
Category: Diseases :: Communicable :: Tuberculosis
Last updated: May 23 2017 01:38 IST RSS 2.0
 
1 to 20 of 11,226    
New path for drug development 22.5.2017 Deccan Herald - Supplements
The 1960s was a decade that witnessed humans setting foot on the moon and a bloody war that changed the history. In between these events, a drug that would be the mainstay for doctors for decades to fight a smart bug, was born. Rifampicin was the last novel class of antibiotics against Mycobacterium tuberculosis till the arrival of bedaquiline at the fag end of 2012. Discovered in 1965, Rifampicin was marketed in Italy in 1968 and was approved by the US regulatory body in 1971. Half-a-century later, it still remains one of the best bets in the hands of doctors to treat the dreaded bacteria that kill millions around the world. Notwithstanding its efficacy, Rifampicin and other medicines used for the first line treatment of tuberculosis (TB) come with a problem. They form a treatment regimen that lasts for six to nine months for standard cases and close to two years for drug resistant ones. The medicine's effectiveness is compromised because of the long duration of the treatment, which leads to poor ...
Also found in: [+]
Govt rolls out fruit-flavoured TB tablets for children 22.5.2017 deccanherald.com
Finally, children suffering from tuberculosis wont have to take the bitter tablets anymore with the government replacing them with strawberry and orange-flavoured ones. The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states and by year end, these fruit flavoured tablets will reach every child of the country, said a senior health ministry official. The doses of these tablets will be decided as per their weight. At present, children diagnosed with TB are given the same bitter-tasting pills, which are actually meant for adult patients, four times a day. The move is aimed at improving the treatment of tuberculosis and child survival rate. These easily-dissolvable and flavoured TB drugs has been rolled out in Sikkim, Himachal Pradesh, Kerala, Bihar and Maharashtra on a pilot basis, said Dr Jagdish Pradash, Director General of Health Services (DGHS). "The drugs will given to children on the basis of their body-weight. For the purpose, body weight has been ...
Also found in: [+]
Govt rolls out fruit-flavoured TB tablets for children 22.5.2017 DNA: Health
The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states and by year end, these fruit flavoured tablets will reach every child of the country, said a senior health ministry official.
Also found in: [+]
GST blow: Medicines to be get costlier as raw materials to be taxed at 18% 22.5.2017 Top Stories
Active pharmaceutical ingredients, or raw materials, will be taxed at 18%
Also found in: [+]
Improper disposal of pharmaceutical waste continues to be a problem 20.5.2017 Hindu: Bangalore
What do you do with a whole box of tablets that were prescribed a while ago but can no longer be used as they have expired or you no longer need them? Throw them in your dustbin, one would say. Only, ...
Also found in: [+]
From Homeless Shelter to Success 20.5.2017 TOI: Chennai
Also found in: [+]
India at 154 behind B'desh, Nepal, China on health care index 20.5.2017 DNA: Health
India has a lot of catching up to do with its neighbours, including China, Bangladesh, Bhutan and Sri Lanka in terms of health care.
Also found in: [+]
Chance of newborn survival: Somalia better off than India 19.5.2017 Hindu: National
India falls 11 places, holds 154th position in Global Burden of Disease rankings
Also found in: [+]
India to become TB free by 2025: Nadda 19.5.2017 New Kerala: India News
India to become TB free by 2025: Nadda
Also found in: [+]
Healthcare shame: India ranked 154th out of 195 countries ranked by Lancet Medical Journal 19.5.2017 DNA: Recent Columns
India has failed to achieve in healthcare goals, badly lagging behind China, Sri Lanka and Bangladesh in terms of accessibility and quality, as per the new Global Burden of Disease study published in the medical journal Lancet. India was ranked 154th position in the ranking of healthcare quality amongst 195 countries, whereas some countries like South Korea, Peru and China have seen greatest improvements in healthcare access and quality since 1990. China, with a score of 74 on the index, has been ranked at 82 - far ahead of India, and Sri Lanka has scored 73 on the index. Similarly, Brazil and Bangladesh have score 65 and 52 respectively. The report also shows that India performed worse than expected in tuberculosis, diabetes, rheumatic heart diseases and chronic kidney disease. "Despite improvements in healthcare quality and access over 25 years, inequality between the best and worst performing countries has grown," said Christopher Murray, director of the Institute for Health Metrics and Evaluation at ...
Also found in: [+]
Donald Trump's global gag order: 5 questions answered 19.5.2017 All International Stories
US put $1.35 billion of money into the Global Fund to Fight AIDS, Tuberculosis and Malaria last year
Also found in: [+]
India ranks below Lanka, Bangladesh on healthcare index 19.5.2017 TOI: India
India continues to be one of the poor performers ranking at 154, much below China, Sri Lanka and even Bangladesh, in terms of quality and accessibility of healthcare, according to the new Global Burden of Disease study published in the Lancet.
Also found in: [+]
Doc publishes max papers on spine TB 18.5.2017 TOI: Delhi Times
Also found in: [+]
Centre tries flavoured pills to help kids finish TB treatment 17.5.2017 TOI: Delhi Times
Also found in: [+]
Strawberry, orange-flavoured pills replace bitter TB tablets 17.5.2017 DNA: Health
By June, the initiative will be rolled out in 17 more states and by the year-end, these flavoured drugs will reach every child of the country, said Dr Jagdish Pradash, Director General of Health Services.
Also found in: [+]
People have a conservative idea about same-sex romance in 'LOEV': Director 17.5.2017 All News-IANS Stories
Gay-themed love story "LOEV" is garnering accolades and is being appreciated at prestigious film festivals on foreign shores. But in India, the film, which explores a same sex romantic relationship, will not even release in theatres and director Sudhanshu Saria says people have a very conservative idea about the film.
Also found in: [+]
National Strategic Plan for TB elimination in 2 months: Dr Sunil Khaparde 17.5.2017 DNA: Health
Interview with Deputy Director General, TB, Ministry of Health and Family Welfare
Also found in: [+]
Ivory Coast holds workshop to deal with TB 16.5.2017 All News-IANS Stories
Abidjan, May 16 (IANS/MAP) Twenty doctors and nurses participated in a training workshop on preventive activities and promotional campaigns against tuberculosis in Ivory Coast's capital Yamoussoukro.
Also found in: [+]
Capsules 15.5.2017 BusinessLine - Specials
HEALTH AMBASSADOR Big B for WHO’s hepatitis campaign The World Health Organization has appointed Amitabh Bachchan as its Goodwill Ambassador for Hepatitis in South-East Asia to boost awareness an...
Also found in: [+]
ICMR to test efficacy of two new TB drugs in clinical trials 14.5.2017 Deccan Herald - National
With India set to witness a steep rise in the number of drug-resistant tuberculosis cases, the Indian Council of Medical Research (ICMR) will test the efficacy of two new medicines for tackling the dreaded bug that causes TB. One of the medicines, Metformin, is widely used to treat type-II diabetes. However, ICMR plans a clinical trial to examine its effectiveness in fighting the TB microbe following encouraging scientific results from Indian biologists. The second drug is Bedaquiline that received the US Food and Drug Administration's approval in 2012 for the treatment of drug-resistant tuberculosis cases. It is yet to be used in India's public-funded national TB control programme. "The protocol for the Metformin trial is ready and we hope to start the trial within a couple of months. The Bedaquiline Delaminate (another new drug) trial for drug-resistant cases may take about six months to kick off," ICMR director general Soumya Swaminathan told DH. The Metformin trial would be held in two steps. First, ...
Also found in: [+]
1 to 20 of 11,226